We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nuformix PLC 05 November 2024 5 November 2024 Nuformix plc ("Nuformix" or the "Company" or the "Group") Director/PDMR Dealings Nuformix plc (LSE:NFX), a pharmaceutical development...
Nuformix PLC 04 November 2024 4 November 2024 Nuformix plc ("Nuformix" or the "Company") Result of General Meeting Nuformix plc (LSE:NFX), a pharmaceutical development company...
Nuformix PLC 16 October 2024 THIS ANNOUNCEMENT AND THE INFORMATION IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN...
Nuformix PLC 20 September 2024 THIS ANNOUNCEMENT AND THE INFORMATION IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN...
ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ...
Nuformix PLC 18 June 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Half Year Report 18 June 2024: Nuformix plc (LSE: NFX), a pharmaceutical development company targeting...
Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further prot ...
Nuformix PLC 17 June 2024 17 June 2024 Nuformix plc ("Nuformix" or the "Company") Patent Update Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet...
Nuformix PLC 19 March 2024 Nuformix plc ("Nuformix" or the "Company") Result of Annual General Meeting Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical...
ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0165 | -23.5714285714 | 0.07 | 0.07 | 0.04 | 38867885 | 0.05467582 | DE |
4 | -0.0115 | -17.6923076923 | 0.065 | 0.07 | 0.04 | 14790057 | 0.05690435 | DE |
12 | -0.1465 | -73.25 | 0.2 | 0.2 | 0.04 | 16168821 | 0.06659966 | DE |
26 | -0.1315 | -71.0810810811 | 0.185 | 0.3 | 0.04 | 9599811 | 0.09362249 | DE |
52 | -0.2215 | -80.5454545455 | 0.275 | 0.44 | 0.04 | 6105544 | 0.12768498 | DE |
156 | -1.8965 | -97.2564102564 | 1.95 | 1.95 | 0.04 | 5077420 | 0.39047565 | DE |
260 | -10.6965 | -99.5023255814 | 10.75 | 11.75 | 0.04 | 4857242 | 1.63477013 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions